| 產(chǎn)品名稱 | Tenilsetam - PAS 997 | CAS 997 | HR 029 |
| 產(chǎn)品貨號 | Axon 1470 CAS [86696-86-8] MF C8H10N2OSMW 182.24 Purity: 99% Soluble in 0.1N HCl(aq) and DMSO Description Endonuclease modulator; a nootropic agent and advanced glycation end product (AGE) inhibitor having potential for Alzheimer's disease (AD) treatment. Preclinical studies on diabetic rats suggested that tenilsetam may be beneficial in the inhibition of diabetic retinopathy, without amelioration of pericyte loss References Certificates Categories Extra info G Munch?et al. The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advance glycosylation. J. Neural. Transm. Sect. 1994, 8(3), 193-208.? ? TJ Roesler et al. Advanced glycation end product (AGE) inhibition as a possible pharmacotherapeutic strategy in the treatment of Alzheimer's disease. Drugs Fut. 1999, 24(4), 411.? Certificate of Analysis Material Safety Data Sheet CNS Diabetes & Metabolism AGE Endonuclease Alzheimer's disease therapeutic Chemical name 3-Thiophen-2-yl-piperazin-2-one Parent CAS No. [86696-86-8] Order Size Unit Price Stock 10 mg €65.00 In Stock |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Tenilsetam - PAS 997 | CAS 997 | HR 029Axon 1470 CAS [86696-86-8] MF C8H10N2OS
DescriptionEndonuclease modulator; a nootropic agent and advanced glycation end product (AGE) inhibitor having potential for Alzheimer's disease (AD) treatment. Preclinical studies on diabetic rats suggested that tenilsetam may be beneficial in the inhibition of diabetic retinopathy, without amelioration of pericyte loss
Alzheimer's disease therapeutic
Chemical name3-Thiophen-2-yl-piperazin-2-one Parent CAS No.[86696-86-8] |
| 產(chǎn)品資料 |
